Close
4

Bora CDMO Bora CDMO

X

Find Esreboxetine Succinate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Looking for 635724-55-9 / Esreboxetine Succinate API manufacturers, exporters & distributors?

Esreboxetine Succinate manufacturers, exporters & distributors 1

40

PharmaCompass offers a list of Esreboxetine Succinate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Esreboxetine Succinate manufacturer or Esreboxetine Succinate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Esreboxetine Succinate manufacturer or Esreboxetine Succinate supplier.

PharmaCompass also assists you with knowing the Esreboxetine Succinate API Price utilized in the formulation of products. Esreboxetine Succinate API Price is not always fixed or binding as the Esreboxetine Succinate Price is obtained through a variety of data sources. The Esreboxetine Succinate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Esreboxetine Succinate

Synonyms

635724-55-9, (s,s)-reboxetine succinate, Esreboxetine succinate [usan], Pnu-165442g, Xqo13w6och, (+)-(2s)-2-((s)-(2-ethoxyphenoxy)phenylmethyl)morpholine hydrogen butanedioate

Cas Number

635724-55-9

Unique Ingredient Identifier (UNII)

XQO13W6OCH

Esreboxetine Succinate Manufacturers

A Esreboxetine Succinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Esreboxetine Succinate, including repackagers and relabelers. The FDA regulates Esreboxetine Succinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Esreboxetine Succinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Esreboxetine Succinate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Esreboxetine Succinate Suppliers

A Esreboxetine Succinate supplier is an individual or a company that provides Esreboxetine Succinate active pharmaceutical ingredient (API) or Esreboxetine Succinate finished formulations upon request. The Esreboxetine Succinate suppliers may include Esreboxetine Succinate API manufacturers, exporters, distributors and traders.

click here to find a list of Esreboxetine Succinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Esreboxetine Succinate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Esreboxetine Succinate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Esreboxetine Succinate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Esreboxetine Succinate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Esreboxetine Succinate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Esreboxetine Succinate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Esreboxetine Succinate suppliers with NDC on PharmaCompass.

Esreboxetine Succinate GMP

Esreboxetine Succinate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Esreboxetine Succinate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Esreboxetine Succinate GMP manufacturer or Esreboxetine Succinate GMP API supplier for your needs.

Esreboxetine Succinate CoA

A Esreboxetine Succinate CoA (Certificate of Analysis) is a formal document that attests to Esreboxetine Succinate's compliance with Esreboxetine Succinate specifications and serves as a tool for batch-level quality control.

Esreboxetine Succinate CoA mostly includes findings from lab analyses of a specific batch. For each Esreboxetine Succinate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Esreboxetine Succinate may be tested according to a variety of international standards, such as European Pharmacopoeia (Esreboxetine Succinate EP), Esreboxetine Succinate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Esreboxetine Succinate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY